Pfizer Settles Kickback Case Related To Copay Assistance For $24M
The drugmaker agreed to a settlement with the Justice Department over allegations that it funneled copay assistance money through a foundation to Medicare patients.
The independent source for health policy research, polling, and news.
6,841 - 6,860 of 15,454 Results
The drugmaker agreed to a settlement with the Justice Department over allegations that it funneled copay assistance money through a foundation to Medicare patients.
Starting in less than two years, if state hospitals haven't met targets for safety and quality, they'll risk being excluded from the "in-network" designation of health plans sold on the state's insurance exchange.
With longer lives and lower rates of dementia, most seniors are enjoying more years of life with good cognition — a welcome trend.
KHN’s Sarah Jane Tribble explains the key elements of the Trump blueprint on CBS News’ "Red & Blue."
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
Anthem, one of the country’s largest insurers, has cut the reimbursement rate it pays for breast pumps by nearly half, fueling concerns that new moms — especially ones with lower incomes — will not be able to afford the pumps they need.
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
Even under a decent plan, you’ll have to dig deep in your pocket for crowns, bridges and implants. The mouth isn’t covered by insurance the same way as the rest of the body, and this division has deep roots in history and tradition.
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
A crowdsourced investigation by KHN and NPR gives voice to those who are puzzled and outraged by medical invoices.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Opioid addiction is often portrayed as a white problem, but overdose rates are now rising faster among Latinos and blacks. Cultural and linguistic barriers may put Latinos at greater risk.
Rates of gonorrhea, syphilis and chlamydia in California have shot up 45 percent over five years, resulting in 30 syphilis-related stillbirths in 2017 alone, new state data show.
In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
© 2026 KFF